Cart
sales@molnova.com
CPA-7
CAS No. 16961-77-6
CPA-7( CPA 7 | CPA7 )
Catalog No. M12586 CAS No. 16961-77-6
A platinum-containing compound that disrupts STAT3 signaling, inhibits cell growth and induces apoptosis in STAT3-activated cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCPA-7
-
NoteResearch use only, not for human use.
-
Brief DescriptionA platinum-containing compound that disrupts STAT3 signaling, inhibits cell growth and induces apoptosis in STAT3-activated cancer cells.
-
DescriptionA platinum-containing compound that disrupts STAT3 signaling, inhibits cell growth and induces apoptosis in STAT3-activated cancer cells; selectively and significantly inhibits Stat3 activation and DNA-binding activity, induces regression of colon tumors in mouse model at 5mg/kg, with the abrogation of persistent Stat3 activity in tumors.
-
In Vitro——
-
In Vivo——
-
SynonymsCPA 7 | CPA7
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorSTAT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number16961-77-6
-
Formula Weight381.501
-
Molecular FormulaCl3H6N3O2Pt
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NamePlatinum, diamminetrichloronitro- (8CI)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Turkson J, et al. Mol Cancer Ther. 2004 Dec;3(12):1533-42.
2. Assi HH, et al. J Pharmacol Exp Ther. 2014 Jun;349(3):458-69.
3. Littlefield SL, et al. Inorg Chem. 2008 Apr 7;47(7):2798-804.
4. Liang M, et al. BMC Cancer. 2016 Jul 19;16:504.
molnova catalog
related products
-
BP-5-087
A potent, selective STAT3 SH2 domain inhibitor (EC50=5.6 uM) that reduces STAT3 phosphorylation and nuclear transactivation.
-
Nirsevimab
Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region, efficiently targeting RSV-B with a Kd value of 1.5 nM, and can be used to prevent RSV infection.
-
HODHBt
HODHBt is a STAT5-SUMO protein-protein interaction inhibitor.
